The study has been approved by ESID.
Proposed by: Julia Körholz, Stuart Turvey and Simran Samra
Contribute to the STAT6GOF international consortium
As you likely know, STAT6 gain-of-function (STAT6GOF) disease is a relatively recently described inborn error of immunity that presents with severe allergic inflammation. ESID just launched a Collaborative Clinical Cohort Study on STAT6GOF disease.The goal of the study is to define the natural history and treatment outcomes of this new inborn error of immunity. Only few patients have been registered in the ESID registry so far, so this is a public call to see if others may have cases to contribute, and if you would like to join our consortium to combine resources. We thank you in advance for your support, on behalf of the STAT6GOF consortium – Julia Körholz, Stuart Turvey and Simran Samra.
Learn more about the project and share your (clinical) expertise to help us build a global resource for better patient care.
Julia.Koerholz@ukdd.de
sturvey@bcchr.ca
Simran.Samra@bcchr.ca